October 2016 Issue - Endovascular Today

Table of Contents

Issue

October 2016

SFA Intervention: The Next Level

Considerations on tomorrow's effectiveness benchmarks.

Supplement

The ISR Treatment Paradigm

Defining the best way to approach femoropopliteal
in-stent restenosis.

In This Issue

Chief Medical Editors' Page

SFA Intervention: The Next Level

By John R. Laird, MD, and Fabrizio Fanelli, MD

Cover Stories

The Future of Femoropopliteal Studies

A discussion on the challenges of applying current trial data and improvements that could guide evidence-based decision making.

By Mehdi H. Shishehbor, DO, MPH, PhD

Ask the Experts: What SFA Trials Would You Most Like to See?

Experts discuss key questions to answer, potential trial designs, and the likelihood that the trials will be undertaken.

With Peter A. Schneider, MD; Thomas Zeller, MD; Osamu Iida, MD; Marianne Brodmann, MD; Krishna Rocha-Singh, MD; and Christopher Metzger, MD

Economic Analysis in Peripheral Artery Disease

Understanding the cost-effectiveness of new devices and treatment strategies.

By Adam C. Salisbury, MD, MSc, and David J. Cohen, MD, MSc

Cost-Effectiveness Analysis of Drug-Eluting Stents and Drug-Coated Balloons

Considerations unique to a single-payor system.

By Konstantinos Katsanos, MSc, MD, PhD, EBIR

Ask the Experts: What Will Dominate the Next Era in SFA Therapy?

Experts discuss the current era of drug-eluting technologies and what might come next.

With Koen Deloose, MD; Craig Walker, MD; and Ramon L. Varcoe, MBBS, MS, FRACS, PhD

The Evolving Role of Preclinical Evaluation in SFA Therapy

Dr. Juan F. Granada discusses the current climate of preclinical research, lessons learned in evaluating drug-eluting technologies, common misconceptions, and what the future holds.

With Juan F. Granada, MD, FACC

Lower Extremity Imaging Wish List: What Capabilities Should We Have By 2021?

A look at the future of lower extremity imaging over the next 5 years.

By Constantino S. Peñ,a, MD

Medical Affairs Corner

October 2016 Supplement

The ISR Treatment Paradigm

Defining the best way to approach femoropopliteal
in-stent restenosis.

In This Issue

October 2016 Supplement

Most Read Articles